Literature DB >> 8528555

Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation.

I K Anderson1, G R Martin, A G Ramage.   

Abstract

1. The aim of the present experiments was to determine whether the effects of lateral ventricular application of 5-HT on cardiovascular and respiratory variables in anaesthetized cats are mediated by forebrain 5-HT2 receptors. This was carried out by determining whether the effects of 5-HT are blocked by the 5-HT2 antagonist, cinanserin and if they are mimicked by the selective 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). 2. Cats were anaesthetized with a mixture of alpha-chloralose and pentobarbitone sodium, neuromuscularly blocked and artifically ventilated. The following cardiovascular and respiratory variables were recorded: renal, splanchnic and cardiac sympathetic nerve activities, phrenic nerve activity, heart rate, arterial blood pressure, femoral arterial conductance and tracheal pressure. All drugs were administered via the lateral ventricle and the action of these agonists was restricted to forebrain sites by a cannula placed in the Aqueduct of Sylvius. 3. Cumulative doses of 5-HT (10-160 nmol kg-1) and DOI (80-320 nmol kg-1) injected into the lateral ventricle caused significant increases in blood pressure, heart rate, cardiac and splanchnic sympathetic nerve activity and a decrease in femoral arterial conductance. DOI and 5-HT caused a greater increase in cardiac compared with splanchnic nerve activity and failed to change renal nerve activity. 5-HT but not DOI significantly increased the magnitude and the number of phrenic bursts as well as significantly increasing tracheal pressure. The effects of 5-HT also differed from DOI in that 5-HT evoked maximal pressor and near maximal sympathoexcitatory effects after the first dose, whereas the pressor and sympathoexcitatory effects of DOI were graded over the complete dose-range.4 The 5-HT2 antagonist, cinanserin (265 nmol kg-1, i.c.v.) caused significant falls in blood pressure,heart rate and cardiac nerve activity and an increase in femoral arterial conductance. Splanchnic andrenal sympathetic nerve activity, phrenic nerve activity and tracheal pressure were unaffected by cinanserin. After pretreatment with cinanserin all cardiovascular and respiratory effects of 5-HT were significantly attenuated.5 It is concluded that in the cat, as DOI and 5-HT have similar effects on the cardiovascular variables recorded and as the effects of 5-HT are blocked by cinanserin, 5-HT can act on 5-HT2 receptors located in the forebrain to cause differential sympathoexcitation and a rise in arterial blood pressure. Further,the sympathoexcitatory effects mediated by 5-HT2 receptors located in the forebrain differ from those located in the hindbrain in that they mediate increases in cardiac nerve activity and heart rate and also have no effect on renal nerve activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528555      PMCID: PMC1909073          DOI: 10.1111/j.1476-5381.1995.tb16658.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.

Authors:  B RUBIN; J J PIALA; J C BURKE; B N CRAVER
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-11-01

2.  Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow.

Authors:  A K Mandal; K J Kellar; W P Norman; R A Gillis
Journal:  Circ Res       Date:  1990-11       Impact factor: 17.367

3.  Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx.

Authors:  K A King; J R Holtman
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

4.  5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.

Authors:  R B McCall; L T Harris
Journal:  Eur J Pharmacol       Date:  1988-06-22       Impact factor: 4.432

5.  Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents.

Authors:  C Mawson; H Whittington
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

Review 6.  The concept of selectivity in 5-HT receptor research.

Authors:  I van Wijngaarden; M T Tulp; W Soudijn
Journal:  Eur J Pharmacol       Date:  1990-06-12       Impact factor: 4.432

7.  Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.

Authors:  R W Fuller; K D Kurz; N R Mason; M L Cohen
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

8.  The central site of the sympatho-inhibitory action of 5-hydroxytryptamine in the cat.

Authors:  J H Coote; D W Dalton; W Fenuik; P P Humphrey
Journal:  Neuropharmacology       Date:  1987 Feb-Mar       Impact factor: 5.250

9.  The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity.

Authors:  A G Ramage
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

10.  Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.

Authors:  A G Ramage
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

View more
  6 in total

1.  Involvement of central 5-HT1A receptors in the reflex activation of pulmonary vagal motoneurones by inhaled capsaicin in anaesthetized cats.

Authors:  D J Bootle; J J Adcock; A G Ramage
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

2.  Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats.

Authors:  I D Knowles; A G Ramage
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 3.  Neural control of the spleen as an effector of immune responses to inflammation: mechanisms and treatments.

Authors:  Clarissa M D Mota; Christopher J Madden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-08-22       Impact factor: 3.210

Review 4.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

5.  Participation of 5-HT and AT1 Receptors within the Rostral Ventrolateral Medulla in the Maintenance of Hypertension in the Goldblatt 1 Kidney-1 Clip Model.

Authors:  Cássia T Bergamaschi; Nyam F Silva; Jose G Pires; Ruy R Campos; Henrique A Futuro Neto
Journal:  Int J Hypertens       Date:  2014-01-21       Impact factor: 2.420

6.  The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner.

Authors:  Tobias Buchborn; Taylor Lyons; Chenchen Song; Amanda Feilding; Thomas Knöpfel
Journal:  J Psychopharmacol       Date:  2020-02-12       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.